Considering even emmetropic eyes elongate, what are the limits of myopia control efficacy? This novel analysis explores the absolute axial elongation of treated and untreated myopes in the MiSight 3-year clinical trial in comparison to previously published models of myopic and emmetropic eye growth. The results indicate a potential limit to the short-term percentage efficacy of myopia control treatments.
MiSight 1 day is a dual focus optical design. Does this affect children’s near vision? What can be done to manage any issues with near vision as noticed by wearers? Read more about expectations and adaptation.
What can you expert in short-term fitting, vision, handling and comfort outcomes in children through to long term outcomes in myopia control, vision and ocular health? This article provides the scientific and clinical basis to get started and continue successfully fitting MiSight 1 day for myopic children.
MiSight 1 day is a dual focus contact lens – it’s not a multifocal as it does not provide an ‘add’ at near. When considering a first correction for a young myope, how should we prioritize both myopia correction and control? Read more in this case.
After the 3-year MiSight 1 day clinical trial, the control group children were switched to MiSight. A ‘virtual control group’ mathematical model, previously published, was utilized to demonstrate a continued myopia control effect across six years, plus effectiveness of treatment for children who commenced wear at age 11-15 years.
Why might a patient experience blurred distance vision with MiSight 1 day contact lenses? Lens fit, centration, prescription and adaptation can all feature. Learn more about the frequency and management of these cases, including the reported outcomes in scientific studies.
The purpose of this 2 year study was to determine the effect of MiSight contact lenses used to control myopia on binocular vision and accommodation in children, as compared with children wearing SV spectacles, with the researches finding no significant differences in binocular and accommodative measures between the study groups.
In this review we explore the 6-year results for MiSight 1 day recently presented at the 2020 American Academy of Optometry meeting. Based on the abstract, children who were older at initial fitting (11-15 years) progressed similarly over 3 years to matched children who were treated for 6 years, indicating that older children could still gain a treatment effect from MiSight 1 day.
When atropine isn’t working as a monotherapy, is it valuable to combine it with a myopia controlling contact lens? Could switching from atropine to a contact lens be the better option? In this post on the Facebook discussion group, a colleague sought opinions on combining atropine and MiSight contact lenses.
Announcing Part 3 of 4 of exciting updates from the 2019 biannual International Myopia Conference! You’ll find links to parts 1, 2 and 4 at the end, however read on for updates on OrthoK, MYLO and MiSight!
